Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Quantitative (Real-time) Polymerase Chain Reaction (PCR) Cycle Threshold (Ct) Values be Used to Predict Poor Outcomes for Patients Infected With SARS-CoV-2? A Local Exploratory Sub-study at The University Hospitals of North Midlands NHS Trust in Collaboration With the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Trial

NCT04651413 is registered in ClinicalTrials.gov with University Hospitals of North Midlands NHS Trust as lead sponsor.

NCT NCT04651413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Quantitative (Real-time) Polymerase Chain Reaction (PCR) Cycle Threshold (Ct) Values be Used to Predict Poor Outcomes for Patients Infected With SARS-CoV-2? A Local Exploratory Sub-study at The University Hospitals of North Midlands NHS Trust in Collaboration With the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 Trial
Lead sponsor
University Hospitals of North Midlands NHS Trust
Phase
Observational
Overall status
Completed
Start date
November 24, 2020
Completion date
October 14, 2021
Enrollment
934 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19